ETON PHARMACEUTICALS INC. - COMMON STOCK
13.44
10-一月-25 16:45:00
15 分钟延时
股票
+1.43
+11.91%
今日范围
11.63 - 13.46
ISIN
N/A
来源
NASDAQ
-
Eton Pharmaceuticals Announces FDA Approval of Rezipres® (Ephedrine Hydrochloride Injection)
15 6月 2021 10:37:52 条件 Nasdaq GlobeNewswire
-
28 5月 2021 08:05:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Reports Record Revenue and Earnings
13 5月 2021 16:05:01 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
04 5月 2021 16:05:01 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Appointment of Jenn Adams to its Board of Directors
17 3月 2021 16:05:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Fourth Quarter and Full Year 2020 Financial Results
16 3月 2021 16:02:00 条件 Nasdaq GlobeNewswire
-
04 3月 2021 16:05:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals to Participate in 10th Annual SVB Leerink Global Healthcare Conference
16 2月 2021 16:05:00 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Sale of Neurology Portfolio
08 2月 2021 08:00:01 条件 Nasdaq GlobeNewswire
-
Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE
14 1月 2021 08:00:01 条件 Nasdaq GlobeNewswire